PGEN vs. BRO

In the year-to-date period, PGEN achieves a 18.75% return, which is significantly higher than BRO's 11.46% return. Over the past 10 years, PGEN has underperformed BRO with an annualized return of -29.75%, while BRO has yielded a comparatively higher 22.42% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Precigen, Inc. (PGEN) and Brown & Brown, Inc. (BRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PGEN Sharpe Ratio is -0.06, which is lower than the BRO Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of PGEN and BRO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PGEN has not paid dividends to shareholders, while BRO's dividend yield for the trailing twelve months is around 0.51%.

The maximum PGEN drawdown since its inception was -99.02%, which is greater than BRO's maximum drawdown of -54.08%. Use the drawdown chart below to compare losses from any high point for PGEN and BRO.

Precigen, Inc. (PGEN) has a higher volatility of 20.69% compared to Brown & Brown, Inc. (BRO) at 4.25%. This indicates that PGEN's price experiences larger fluctuations and is considered to be riskier than BRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Precigen, Inc. and Brown & Brown, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.